Evidence map›Paper›PMID 25947378›Full record

ReviewThe Journal of biological chemistry2015

The Alpha and Omega of Galactosylceramides in T Cell Immune Function.

Alysia M Birkholz, Amy R Howell, Mitchell Kronenberg

Erratum issuedOpen access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Alysia M BirkholzDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California 92037; Division of Biological Sciences, University of California, San Diego, La Jolla, California 92037.
Amy R HowellDepartment of Chemistry, University of Connecticut, Storrs, Connecticut 06269.
Mitchell KronenbergDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California 92037; Division of Biological Sciences, University of California, San Diego, La Jolla, California 92037. Electronic address: mitch@lji.org.
La Jolla Institute for Immunology · USUniversity of California, San Diego · USUniversity of Connecticut · US

Funding

Development and Function of NKT CellsR37AI071922 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2006 to 2015
$4.9M
The role of natural killer T cells in the innate response to lung infectionR01AI105215 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2014 to 2018
$2.2M
NIAID NIH HHS R01 AI105215NIAID NIH HHS R37 AI071922NIAID NIH HHS R37 AI71922
6 · The paper itself

Abstract

Glycosphingolipids are a subgroup of glycolipids that contain an amino alcohol sphingoid base linked to sugars. They are found in the membranes of cells ranging from bacteria to vertebrates. This group of lipids is known to stimulate the immune system through activation of a type of white blood cell known as natural killer T cell (NKT cell). Here we summarize the extensive research that has been done to identify the structures of natural glycolipids that stimulate NKT cells and to determine how these antigens are recognized. We also review studies designed to understand how glycolipid variants, both natural and synthetic, can alter the responses of NKT cells, leading to dramatic changes in the global immune response.

Indexed as

AnimalsAntigensGalactosylceramidesHumansImmunity, CellularNatural Killer T-CellsAntigensGalactosylceramidesceramidecytokineglycolipid structureimmunologylipid

Identifiers

PMID25947378
PMCPMC4505449
OpenAlexW1564340815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.